Recent Updates — NUMD

The Board of Directors amended the Company’s Bylaws effective November 2, 2026, to add a provision requiring the affirmative vote of a majority of votes cast by shares present or represented at a meeting with a quorum for any transfer of domicile or domestication in a jurisdiction other than Utah. The filing also announced that the 2026 Annual Meeting will be held virtually on December 14, 2026, with a record date of November 6, 2026. Nu-Med Plus operates in the medical device and distribution industry.

On October 19, 2026, Nu-Med Plus entered into subscription agreements to sell 171,232 shares of Series A Preferred Stock to two accredited investors for an aggregate of $450,000, or $2.628 per share. The company also issued 50,000 additional shares of the same preferred stock to a consultant in exchange for services rendered. These unregistered securities carry piggy-back registration rights and convert into common stock at specified ratios. Nu-Med Plus operates in the medical device distribution sector.

Nu-Med Plus, Inc. completed the acquisition of six gold mineral properties in Nova Scotia, New Brunswick, and Newfoundland and Labrador through its subsidiary Maritimes Gold Corp. The transaction closed on August 20, 2026, following shareholder approval by MegumaGold Corp., which held approximately 84.5% of voting shares. Consideration included the issuance of 500,000 shares of Series A Preferred Stock to MegumaGold and the granting of 5.0% net smelter returns royalties on each property. The preferred stock is convertible into up to 10,000,000 common shares and includes a contingent value protection mechanism requiring additional equity issuance if gross proceeds from share sales fall below $3.0 million within three years. Nu-Med Plus, Inc. operates in the gold mining industry.

Nu-Med Plus, Inc. closed an acquisition of Avid Gold Ltd., making it a wholly-owned subsidiary. The transaction involved the issuance of 4,500,000 shares of Series A Preferred Stock and the assumption of a $100,000 promissory note. As part of the agreement, the company is seeking shareholder approval for a 1-for-27 reverse stock split, an increase in authorized shares to 500,000,000, and a redomicile from Utah to Nevada. Nu-Med Plus, Inc. operates in the exploration and mining industry.